Boston Family Office LLC Sells 2,030 Shares of Zebra Technologies Corporation $ZBRA

Key Points

• Boston Family Office LLC reduced its stake in Zebra Technologies by 3.4% during the first quarter, now holding 56,920 shares valued at approximately $16.08 million.
• Several institutional investors increased their positions, with American Century Companies Inc. raising its stake by 63.3% and Aberdeen Group plc boosting its holdings by 106.5% in the same quarter.
• Zebra Technologies reported earnings of $3.61 per share for the last quarter, exceeding analysts' expectations and marking a 6.2% year-over-year revenue increase.

Boston Family Office LLC lowered its position in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 3.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 56,920 shares of the industrial products company's stock after selling 2,030 shares during the quarter. Zebra Technologies accounts for approximately 1.1% of Boston Family Office LLC's investment portfolio, making the stock its 29th biggest holding. Boston Family Office LLC owned 0.11% of Zebra Technologies worth $16,083,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of ZBRA. Investment Management Corp VA ADV purchased a new stake in shares of Zebra Technologies during the 4th quarter worth approximately $27,000. Zions Bancorporation National Association UT purchased a new stake in shares of Zebra Technologies during the 1st quarter worth approximately $27,000. Cary Street Partners Investment Advisory LLC purchased a new stake in shares of Zebra Technologies during the 1st quarter worth approximately $29,000. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in shares of Zebra Technologies during the 1st quarter worth approximately $30,000. Finally, Coppell Advisory Solutions LLC purchased a new position in Zebra Technologies in the 4th quarter valued at approximately $36,000. Institutional investors own 91.03% of the company's stock.

Zebra Technologies Price Performance

Shares of Zebra Technologies stock traded down $0.42 during trading on Monday, hitting $317.48. The stock had a trading volume of 360,129 shares, compared to its average volume of 670,996. The firm has a market cap of $16.14 billion, a price-to-earnings ratio of 29.98 and a beta of 1.75. Zebra Technologies Corporation has a 12 month low of $205.73 and a 12 month high of $427.76. The business's 50-day moving average is $316.84 and its 200 day moving average is $295.81. The company has a current ratio of 1.46, a quick ratio of 1.03 and a debt-to-equity ratio of 0.59.

Zebra Technologies (NASDAQ:ZBRA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The industrial products company reported $3.61 earnings per share for the quarter, topping the consensus estimate of $3.31 by $0.30. The firm had revenue of $1.29 billion for the quarter, compared to analysts' expectations of $1.29 billion. Zebra Technologies had a net margin of 10.56% and a return on equity of 18.95%. The business's quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.18 earnings per share. As a group, sell-side analysts anticipate that Zebra Technologies Corporation will post 13.71 earnings per share for the current year.

Zebra Technologies announced that its board has initiated a stock repurchase plan on Tuesday, August 5th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the industrial products company to repurchase up to 1.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ZBRA. BNP Paribas Exane upgraded shares of Zebra Technologies from a "neutral" rating to an "outperform" rating and set a $408.00 price objective for the company in a research note on Thursday, July 10th. UBS Group reduced their price objective on shares of Zebra Technologies from $425.00 to $410.00 and set a "buy" rating for the company in a research note on Wednesday, April 30th. Barclays set a $301.00 price objective on shares of Zebra Technologies and gave the company an "equal weight" rating in a research note on Tuesday, August 5th. Robert W. Baird lifted their price objective on shares of Zebra Technologies from $320.00 to $367.00 and gave the company an "outperform" rating in a research note on Monday, July 14th. Finally, Truist Financial lifted their price objective on shares of Zebra Technologies from $269.00 to $319.00 and gave the company a "hold" rating in a research note on Wednesday, August 6th. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $357.44.

Zebra Technologies Profile

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.